Add New Product | My Products | Free Product Alert
Sell Offers | Buy Offers | Products | Companies

Keyword "pharmaceutical"
advertisements
Anti-HPV E6 Intrabody [Tat] Anti-HPV E6 Intrabody [Tat]

Recombinant anti-HPV E6 intrabody in fusion with HIV Tat works within cells and specifically reacts with HPV E6, expressed in E. coli cells.

http://www.creativebiolabs.net/Anti-HPV-E6-Intrabody-Tat-13285.htm

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
Anti-HPV E6 Intrabody [+36GFP] Anti-HPV E6 Intrabody [+36GFP]

Recombinant anti-HPV E6 intrabody in fusion with +36GFP works within cells to bind HPV E6, expressed in E. coli cells.

http://www.creativebiolabs.net/Anti-HPV-E6-Intrabody-36GFP-13284.htm

 

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
advertisements
Anti-HPV E6 Intrabody [(D-Arg)9 Anti-HPV E6 Intrabody [(D-Arg)9

Recombinant anti-HPV E6 intrabody linked to (D-Arg)<sub>9</sub> works within cells to bind HPV E6, expressed in E. coli cells.

http://www.creativebiolabs.net/Anti-HPV-E6-Intrabody-D-Arg-9-13283.htm

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
Anti-G3BP1 Intrabody [+36GFP] Anti-G3BP1 Intrabody [+36GFP]

Recombinant anti-G3BP1 intrabody in fusion with +36GFP works within cells to bind human G3BP1, expressed in 293T cells.

http://www.creativebiolabs.net/Anti-G3BP1-Intrabody-36GFP-13311.htm

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
advertisements
Anti-TGM2 Intrabody [Tat] Anti-TGM2 Intrabody [Tat]

Recombinant anti-TGM2 intrabody in fusion with HIV Tat works within cells and directes to antigen human TGM2, expressed in CHO cells. The intracellular antibody can inhibit the ransglutaminase activity may be by one or more techniques, including, but not limited to, downregulating transglutaminase expression, inhibiting TG2 translation, or blocking TG2 enzymatic activity.

http://www.creativebiolabs.net/Anti-TGM2-Intrabody-Tat-13309.htm

 

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
Anti-TGM2 Intrabody [+36GFP] Anti-TGM2 Intrabody [+36GFP]

Recombinant anti-TGM2 intrabody in fusion with +36GFP works within cells and directes to antigen human TGM2, expressed in CHO cells. The intracellular antibody can inhibit the ransglutaminase activity may be by one or more techniques, including, but not limited to, downregulating transglutaminase expression, inhibiting TG2 translation, or blocking TG2 enzymatic activity.

http://www.creativebiolabs.net/Anti-TGM2-Intrabody-36GFP-13308.htm

 

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
advertisements
Anti-TGM2 Intrabody [(D-Arg)9 Anti-TGM2 Intrabody [(D-Arg)9

Recombinant anti-TGM2 intrabody linked to (D-Arg)9 works within cells and directes to antigen human TGM2, expressed in CHO cells. The intracellular antibody can inhibit the ransglutaminase activity may be by one or more techniques, including, but not limited to, downregulating transglutaminase expression, inhibiting TG2 translation, or blocking TG2 enzymatic activity.

http://www.creativebiolabs.net/Anti-TGM2-Intrabody-D-Arg-9-13307.htm

 

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
Anti-RAS Intrabody [Tat] Anti-RAS Intrabody [Tat]

Recombinant anti-RAS intrabody in fusion with HIV Tat works within cells to bind human RAS, expressed in E. coli cells. An intracellular antibody constructed by the single chain antibody can inhibit proliferations and invasion abilities of the human tumor cells with highly expressed p21ras proteins.

http://www.creativebiolabs.net/Anti-RAS-Intrabody-Tat-13432.htm

 

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
advertisements
Anti-RAS Intrabody [+36GFP] Anti-RAS Intrabody [+36GFP]

Recombinant anti-RAS intrabody in fusion with +36GFP works within cells to bind human RAS, expressed in E. coli cells. An intracellular antibody constructed by the single chain antibody can inhibit proliferations and invasion abilities of the human tumor cells with highly expressed p21ras proteins.

http://www.creativebiolabs.net/Anti-RAS-Intrabody-36GFP-13431.htm

 

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
Anti-ERBB2 Intrabody [Tat] Anti-ERBB2 Intrabody [Tat]

Recombinant anti-ERBB2 intrabody in fusion with HIV Tat targetes to the lumen of the endoplasmic reticulum prevent the transit of EGFR or the related ErbB2 molecule to the cell surface, thereby inactivating their transforming potential, expressed in CHO cells.

http://www.creativebiolabs.net/Anti-ERBB2-Intrabody-Tat-13306.htm

 

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
advertisements
Anti-ERBB2 Intrabody [+36GFP] Anti-ERBB2 Intrabody [+36GFP]

Recombinant anti-ERBB2 intrabody in fusion with +36GFP targetes to the lumen of the endoplasmic reticulum prevent the transit of EGFR or the related ErbB2 molecule to the cell surface, thereby inactivating their transforming potential, expressed in CHO cells.

http://www.creativebiolabs.net/Anti-ERBB2-Intrabody-36GFP-13305.htm

 

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
Anti-ERBB2 Intrabody [(D-Arg)9 Anti-ERBB2 Intrabody [(D-Arg)9

Recombinant anti-ERBB2 intrabody linked to (D-Arg)9 targetes to the lumen of the endoplasmic reticulum prevent the transit of EGFR or the related ErbB2 molecule to the cell surface, thereby inactivating their transforming potential, expressed in CHO cells.

http://www.creativebiolabs.net/Anti-ERBB2-Intrabody-D-Arg-9-13304.htm

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
advertisements
Anti-PREV Intrabody [Tat] Anti-PREV Intrabody [Tat]

Recombinant anti-PREV intrabody in fusion with HIV Tat works within cells to bind secifically to a retrovirus protein PREV particle protein, expressed in 293T cells. Intracellular antibody which disrupts the catalysis of the production of the xenoantigen galactose α 1,3 galactose and/or a polynucleotide construct which encodes an intracellular antibody which binds specifically to a retrovirus protein, such as a PERV particle protein.

http://www.creativebiolabs.net/Anti-PREV-Intrabody-Tat-13459.htm

 

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
IL-10-PE immunotoxin IL-10-PE immunotoxin

This immunotoxin was achieved by conjugating/fusing the IL-10 to Pseudomonas exotoxin. It was expressed in CHO and purified with affinity chromatography. The immunotoxin selectively binds to tumor cells. Once bind, the toxin enters cells by receptor-mediated endocytosis. Then PE cleaved fragments the size of Mr 37000 and 27000, the large fragment and finally into the Golgi and elongation factor 2 (EM) combining it glycosylation inactivation, inhibition of protein synthesis, leading to apoptosis. It was designed for treating peritonic tumor. http://www.creativebiolabs.net/IL-10-PE-immunotoxin-17286.htm

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
advertisements
Anti-HSV-2 gD immunotoxin R33 (VHH)-PE Anti-HSV-2 gD immunotoxin R33 (VHH)-PE

This immunotoxin was achieved by conjugating/fusing the Anti-HSV-2 gD VHH to Pseudomonas exotoxin. It was expressed in CHO and purified with affinity chromatography. The immunotoxin selectively binds to infected cells. Once bind, the toxin enters cells by receptor-mediated endocytosis. Then PE cleaved fragments the size of Mr 37000 and 27000, the large fragment and finally into the Golgi and elongation factor 2 (EM) combining it glycosylation inactivation, inhibition of protein synthesis, leading to apoptosis. It was designed for treating herpes simplex virus 2 (HSV-2) infection. http://www.creativebiolabs.net/Anti-HSV-2-gD-VHH-PE-immunotoxin-17271.htm

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
Anti-HIV-1 immunotoxin 3B3 (scFv)-PE Anti-HIV-1 immunotoxin 3B3 (scFv)-PE

This immunotoxin was achieved by conjugating/fusing the Anti-HIV-1 scFv to Pseudomonas exotoxin. It was expressed in CHO and purified with affinity chromatography. The immunotoxin selectively binds to infected cells. Once bind, the toxin enters cells by receptor-mediated endocytosis. Then PE cleaved fragments the size of Mr 37000 and 27000, the large fragment and finally into the Golgi and elongation factor 2 (EM) combining it glycosylation inactivation, inhibition of protein synthesis, leading to apoptosis. It was designed for treating immunodeficiency virus type 1 (HIV-1) infection. http://www.creativebiolabs.net/Anti-HIV-1-scFv-PE-immunotoxin-17256.htm

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
advertisements
Anti-HIV-1 immunotoxin 3B3 (scFv)-DT Anti-HIV-1 immunotoxin 3B3 (scFv)-DT

This immunotoxin was achieved by conjugating/fusing the Anti-HIV-1 scFv to Diphtheria toxin. It was expressed in CHO and purified with affinity chromatography. The immunotoxin selectively binds to infected cells and the toxin enters cells by receptor-mediated endocytosis. Before the N-terminal 193 amino acids corresponding to the catalytic domain of DT enzyme, -II binding and elongation factor into the eukaryotic cell, the cell can catalyze specific elongation factor EF2 amide His699 of diphtheria ADP2 ribosylation occurs, thereby preventing protein synthesis and causes cell death. It was designed for treatment of immunodeficiency virus type 1 (HIV-1) infection. http://www.creativebiolabs.net/Anti-HIV-1-scFv-DT-immunotoxin-17257.htm

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
Anti-Gpc3 immunotoxin (scFv)-PE Anti-Gpc3 immunotoxin (scFv)-PE

This immunotoxin was achieved by conjugating/fusing the Anti-Gpc3 scFv to Pseudomonas exotoxin. It was expressed in CHO and purified with affinity chromatography. The immunotoxin selectively binds to tumor cells. Once bind, the toxin enters cells by receptor-mediated endocytosis. Then PE cleaved fragments the size of Mr 37000 and 27000, the large fragment and finally into the Golgi and elongation factor 2 (EM) combining it glycosylation inactivation, inhibition of protein synthesis, leading to apoptosis. It was designed for treating liver cancer. http://www.creativebiolabs.net/Anti-Gpc3-scFv-PE-immunotoxin-17241.htm

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
advertisements
Anti-GPA33 immunotoxin (scFv)-α-sar Anti-GPA33 immunotoxin (scFv)-α-sar

This immunotoxin was achieved by conjugating/fusing the Anti-GPA33 scFv to α-sarcin. It was expressed in CHO and purified with affinity chromatography. The immunotoxin selectively binds to GPA33 tumor antigen expressing cells. Once bind, alpha-Sarcin enters into the cells by receptor-mediated endocytosis and interacts with a single bond in the targeted ribosome and breaks it, causing the ribosome to be inactivated. It was designed for treatment of colon cancer. http://www.creativebiolabs.net/Anti-GPA33-scFv-α-sar-immunotoxin-17240.htm

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
Anti-GNRH1 immunotoxin (scFv)-PE Anti-GNRH1 immunotoxin (scFv)-PE

This immunotoxin was achieved by conjugating/fusing the Anti-GNRH1 scFv to Pseudomonas exotoxin. It was expressed in CHO and purified with affinity chromatography. The immunotoxin selectively binds to HeLa cells. Once bind, the toxin enters cells by receptor-mediated endocytosis. Then PE cleaved fragments the size of Mr 37000 and 27000, the large fragment and finally into the Golgi and elongation factor 2 (EM) combining it glycosylation inactivation, inhibition of protein synthesis, leading to apoptosis. It was designed for treating cervical cancer. http://www.creativebiolabs.net/Anti-GNRH1-scFv-PE-immunotoxin-17211.htm

[Related Categories: Drugs & Medications ]
[Related Keywords: pharmaceutical ]
1 2 3 4 5 6 7 8 9 10  >> 
Scroll